| Entry |
|
| Name |
Holocarboxylase synthetase deficiency
|
| Description |
Holocarboxylase synthetase deficiency is an autosomal recessive disorder of biotin metabolism that results from biotinidase or holocarboxylase synthetase activity disruption.
|
| Category |
Inherited metabolic disease
 |
| Pathway |
|
| Gene |
HLCS; holocarboxylase synthetase [HSA: 3141] [KO: K01942]
|
| Drug |
|
| Other DBs |
|
| Reference |
|
| Authors |
Suzuki Y, Yang X, Aoki Y, Kure S, Matsubara Y |
| Title |
Mutations in the holocarboxylase synthetase gene HLCS. |
| Journal |
Hum Mutat 26:285-90 (2005) |
| Reference |
|
| Authors |
Pacheco-Alvarez D, Solorzano-Vargas RS, Del Rio AL |
| Title |
Biotin in metabolism and its relationship to human disease. |
| Journal |
Arch Med Res 33:439-47 (2002) |